在葡萄牙的前列腺癌治疗:全国性的分析
Francisco Botelho1,2, Rui Lopes3, Francisco Pina4,5
1Serviço de Urologia do Centro Hospitalar Universitário S. João, Alameda Hernâni Monteiro, 4200-319, Porto, Portugal. francisco.botelho@gmail.com.
Scientific reports
|November 8, 2023
概括
在葡萄牙,前列腺癌的治疗增加了,但激进前列腺切除术和胸膜治疗的高容量中心有限. 集中这些治疗方法可以改善结果.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 局部性前列腺癌提供了各种治疗方式.
- 高体积的医院执行程序与改善的患者结果相关.
- 了解治疗趋势和医院容量对于优化护理提供至关重要.
研究的目的:
- 分析葡萄牙国家卫生系统中前列腺癌治疗的时间趋势.
- 评估整个医院的急性前列腺切除术 (RP),支臂疗法 (BT) 和外部放射疗法 (eRT) 的病例数量分布.
- 确定集中治疗的机会,以提高医院病例数量.
主要方法:
- 使用了葡萄牙国家诊断相关组数据库.
- 检查了国家卫生系统医院执行的RP,BT和eRT程序的数据.
- 分析了治疗数量,医院病例数量以及RP数量与停留时间之间的相关性.
主要成果:
- 在2006年之前观察到RP的显著增长,随后出现减速;在2011年之前增加了BT;在2010年之后,eRT超过了RP.
- 少数医院处理了大多数RP和BT手术.
- 大多数执行eRT的医院实现了高年病例数量;在RP医院数量和停留时间之间发现了负相关性.
结论:
- 葡萄牙国家卫生服务局已经看到前列腺癌治疗的大幅增加.
- 有很大的潜力集中激进前列腺切除术和支臂治疗程序在更高体积的中心.
- 改善特定治疗的医院病例数量可能会带来更好的医疗保健效率和更好的患者结果.
相关概念视频
01:21Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K